#United States #Washington D.C. #BIRD Foundation #Tech Innovation #U.S.-Israel Projects

Innovative Collaborations Funded by BIRD Foundation

In a remarkable move to foster technological and economic collaboration, the BIRD Foundation has granted a total of $7.5 million towards seven new projects that involve partnerships between U.S. and Israeli companies. This funding was approved by the Board of Governors of the Israel-U.S. Binational Industrial Research and Development Foundation on May 5, 2026. Amid a broader investment expectation of roughly $20 million across these projects, the BIRD Foundation continues to serve as a catalyst for innovation in various sectors, including agriculture, cybersecurity, healthcare, and pharmaceuticals.

Over the past 49 years, the BIRD Foundation has backed more than 1,200 collaborations, allocating approximately $465 million to joint efforts that have yielded over $10 billion in direct and indirect revenue. This latest funding cycle aligns with the Foundation’s mission of promoting strategic partnerships between American and Israeli tech firms, thereby accelerating innovative solutions that address pressing global challenges.

Project Highlights

The newly funded initiatives showcase an impressive array of technological advancements:
1. Brevel (Kiryat Gat, Israel) with Ayana Bio (Boston, MA): Developing scalable plant cell cultivation using illuminated fermentation technology for plant-based bioactive ingredients.
2. Ensights AI Renewable Energy (Beit Halevi, Israel) with Solitude Labs (West Palm Beach, FL): Working on next-generation cybersecurity solutions for critical infrastructure operational technology systems.
3. Greeneye (Tel Aviv, Israel) with Nutrien Ag Solutions (Loveland, CO): Creating an AI-driven targeted spraying system for agricultural retailers that can revolutionize farming practices.
4. HT Vet (Hod Hasharon, Israel) with VCA Animal Hospitals (Los Angeles, CA): Innovations in non-invasive tumor screening for cats and expanded diagnostics capabilities for dogs through the VISTA IQ platform.
5. Identifai-Genetics (Tel Aviv, Israel) with Inocras Inc. (San Diego, CA): Focusing on a U.S. clinical introduction of a genome-wide prenatal test for genetic disorders.
6. Neurogenesis (Givatayim, Israel) with OrganaBio (South Miami, FL): Developing a novel cell therapy to treat progressive multiple sclerosis, addressing an urgent medical need.
7. NeuroKaire (Tel Aviv, Israel) with MindfulCare (New York, NY): Aiming to craft tailored precision treatments to improve outcomes for patients battling depression.

Driving Forces Behind the Funding

Dr. Alon Stopel, who serves as the Chief Scientist of Innovation at the Ministry of Innovation, Science and Technology, highlighted the vital role of these projects in enhancing U.S.-Israel technological alliances. He stated, "The selected projects reveal the depth and dynamic nature of our partnership. This collaboration is not just about technology transfer but also about nurturing innovative ecosystems that tackle significant global challenges."

Similarly, Mr. Mike Molnar, Director of the Advanced Manufacturing Office at the U.S. National Institute of Standards and Technology (NIST), praised the grant recipients, noting how the projects align with the BIRD Foundation’s goal of driving impactful innovation. He remarked, "By promoting joint R&D partnerships, we are enabling strides in critical sectors, from advanced agriculture to groundbreaking health therapies."

Mr. Jaron Lotan, Executive Director of the BIRD Foundation, emphasized that these projects embody the unique collaborative spirit shared by American and Israeli firms. "By merging complementary technologies and expertise, we are witnessing outcomes far exceeding individual efforts. Such partnerships empower innovation and address market needs effectively," he stated.

Looking Ahead

As the BIRD Foundation moves forward, companies interested in its next funding cycle are encouraged to submit Executive Summaries by the deadline of November 19, 2026, with project approvals anticipated in March 2027.

The BIRD Foundation continues to play a pivotal role in creating frameworks for innovation between the U.S. and Israel. Its endeavors not only promote economic growth but also position both countries at the forefront of technological advancement, ensuring they remain competitive in a rapidly evolving global market.

This latest round of funding underscores the potential of binational collaboration in varying sectors, promising exciting developments to come in essential industries and improving the lives of people across the globe.